Drug Profile
Clindamycin/tretinoin - 3SBio
Alternative Names: KW 303Latest Information Update: 18 Dec 2019
Price :
$50
*
At a glance
- Originator 3SBio
- Class Antiacnes; Antibacterials; Keratolytics; Lincosamides; Retinoids; Small molecules
- Mechanism of Action Protein 50S ribosomal subunit inhibitors; Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acne vulgaris
Most Recent Events
- 18 Dec 2019 No development reported - Phase-III for Acne vulgaris in China (Topical)
- 25 Jan 2016 Phase-III clinical trials in Acne vulgaris in China (Topical)